ArticleJournal of global health2025
Long-term impact of COVID-19-related nonpharmaceutical interventions on tuberculosis: an interrupted time series analysis using Bayesian method.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impact of nonpharmaceutical interventions on infectious disease patterns in Yunnan Province across the COVID-19 pandemic phases.BMC infectious diseases · 2026Article
- Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning.BMC infectious diseases · 2025Article
- Forecasting tuberculosis epidemics using an autoregressive fractionally integrated moving average model: a 17-year time series analysis.Journal of global health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic may inadvertently influence the epidemiology of tuberculosis (TB). (TB). However, few studies have explored how NPIs impact the long-term epidemiological trends of TB. We aimed to estimate the impact of NPIs implemented against COVID-19 on the medium- and long-term TB epidemics and to forecast the epidemiological trend of TB in Henan. Methods: We first collected monthly TB case data from January 2013 to September 2022, after which we used the data from January 2013 to December 2021 as a training data set to fit the Bayesian structural time series (BSTS) model and the remaining data as a testing data set to validate the model's predictive accuracy. We then conducted an intervention analysis using the BSTS model to evaluate the impact of the COVID-19 pandemic on TB epidemics and to project trends for the upcoming years. Results: A total of 590 455 TB cases were notified from January 2013 to September 2022, resulting in an annual incidence rate of 57.4 cases per 100 000 population, with a monthly average of 5047 cases (5.35 cases per 100 000 population). The trend in TB incidence showed a significant decrease during the study period, with an annual average percentage change of -7.3% (95% confidence interval (CI) = -8.4, -6.1). The BSTS model indicated an average monthly reduction of 25% (95% CI = 17, 32) in TB case notifications from January 2020 to December 2021 due to COVID-19 (probability of causal effect = 99.80%, P = 0.002). The mean absolute percentage error in the forecast set was 14.86%, indicating relatively high predictive accuracy of the model. Furthermore, TB cases were projected to total 43 584 (95% CI = 29 471, 57 291) from October 2022 to December 2023, indicating a continued downward trend. Conclusions: COVID-19 has had medium- and long-term impacts on TB epidemics, while the overall trend of TB incidence in Henan is generally declining. The BSTS model can be an effective option for accurately predicting the epidemic patterns of TB, and its results can provide valuable technical support for the development of prevention and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.